The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids

The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of internal medicine Ročník 294; číslo 3; s. 281 - 294
Hlavní autoři: Bäckström, Torbjörn, Turkmen, Sahruh, Das, Roshni, Doverskog, Magnus, Blackburn, Thomas P.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Blackwell Publishing Ltd 01.09.2023
Témata:
Acetic acid
Aged
allopregnanolone
Alzheimer Disease - drug therapy
Alzheimer's disease
Animal cognition
Animals
Central nervous system
Cognition
Cognitive ability
Cognitive Dysfunction - drug therapy
dementia
Dementia disorders
GABA-A receptor
gamma-Aminobutyric Acid - pharmacology
Hepatic encephalopathy
Humans
Impairment
Medroxyprogesterone acetate
Memory
Neurodegenerative diseases
Neurosteroids
Neurosteroids - therapeutic use
Pregnanolone
Pregnanolone - pharmacology
Receptors
Receptors, GABA-A
Steroid hormones
Steroids
Transgenic animals
γ-Aminobutyric acid
dementia
allopregnanolone
memory
GABA-A receptor
neurosteroids
ISSN:0954-6820, 1365-2796, 1365-2796
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA‐A receptor modulating stress and sex steroids (steroid‐PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA‐A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid‐PAMs and opportunities to treat these adverse effects of steroid‐PAMs with novel GAMSAs.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0954-6820
1365-2796
1365-2796
DOI:10.1111/joim.13705